Publications While At Healthpartners
Consensus recommendations for the use of automated insulin delivery technologies in clinical practice
Young children have higher variability of insulin requirements: observations during hybrid closed-loop insulin delivery
Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial
Lancet (London, England).
Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol
Duration of hybrid closed-loop insulin therapy to achieve representative glycemic outcomes in adults with type 1 diabetes [editorial]
Diabetes care. 43.
Hybrid closed-loop in adults with type 1 diabetes: impact of baseline A1c on glucose outcomes and insulin delivery [poster]
Optimal sampling duration of hybrid closed-loop therapy to determine long-term glycemic control in adults with type 1 diabetes [poster]
Biomarkers for the diagnosis of heart failure in people with diabetes: a consensus report from Diabetes Technology Society [review]
Progress in Cardiovascular Diseases.
Map of science